J. Thomas

Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

R. Rosenheck, D. Charney, D. Perlick, 2000, The Journal of clinical psychiatry.

Quality of Life in Schizophrenia: A Comparison of Instruments

R. Rosenheck, J. Cramer, D. Charney, 2000 .

Detecting improvement in quality of life and symptomatology in schizophrenia.

R. Rosenheck, J. Cramer, D. Charney, 2001, Schizophrenia bulletin.

Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol.

R. Rosenheck, D. Charney, W. Henderson, 2000, The Journal of clinical psychiatry.

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

R. Rosenheck, J. Cramer, D. Charney, 1997, The New England journal of medicine.

Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention.

K. Wenzel, Victoria L. Selby, M. Fishman, 2021, Journal of substance abuse treatment.